Clear Cell Sarcoma (CCS)
3 clinical trials · Condition
◉ Watch Clear Cell Sarcoma (CCS)
| Record | Firm | Date |
|---|---|---|
| Phase 2 Study in Patients With MiT Tumors (NCT00557609) | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 2007-10-01 |
Track Clear Cell Sarcoma (CCS) automatically
Every clearance here is in the API, with alerts when new ones post.